Trinity Biotech Announces Results for Q1, 2021
May 25, 2021 08:48 ET
|
Trinity Biotech plc
DUBLIN, Ireland, May 25, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech plc to Announce First Quarter Fiscal Year 2021 Financial Results
May 19, 2021 12:43 ET
|
Trinity Biotech plc
DUBLIN, Ireland, May 19, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech Announces the Submission of TrinScreen™ HIV to the World Health Organisation for Approval
March 30, 2021 09:00 ET
|
Trinity Biotech plc
DUBLIN, Ireland, March 30, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) has submitted its new HIV screening product, TrinScreen™ HIV, to the World Health Organisation (WHO) for...
Trinity Biotech Announces Quarter 4 and Fiscal Year 2020 Financial Results
March 25, 2021 09:28 ET
|
Trinity Biotech plc
DUBLIN, Ireland, March 25, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2020 Financial Results
March 23, 2021 16:15 ET
|
Trinity Biotech plc
DUBLIN, Ireland, March 23, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech Announces CE Mark of its Covid-19 IgG ELISA Antibody Test
January 05, 2021 08:04 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) has achieved CE Mark approval and registration for its Covid-19 IgG ELISA antibody test, the Captia™ SARS-CoV-2...
Trinity Biotech Announces Results for Q3, 2020
November 17, 2020 09:12 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech plc to Announce Third Quarter 2020 Financial Results
October 29, 2020 10:38 ET
|
Trinity Biotech plc
DUBLIN, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will...
Trinity Biotech Announces Results for Q2, 2020
August 25, 2020 09:40 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech announces EUA submission for Covid-19 ELISA Antibody test
August 20, 2020 10:31 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Aug. 20, 2020 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...